Results

Total Results: 2,752 records

Showing results for "intervention".

2561. Draft-Living-Review-Plant-Chronic-Pain-E-Cohort-Studies (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/draft-living-review-plant-chronic-pain-e-cohort-studies.xlsx
      March 25, 2024 - 33764103 Gruber, 2021 Prospective cohort U.S Mixed musculoskeletal Mixed Mean 53 62* *only reported for intervention

2562. S143 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/s143.pdf
      October 01, 2007 - The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group.

2563. Layout 1 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label_executive.pdf
      January 01, 2007 - A large head-to-head placebo controlled trial (Clinical Antipsychotic Trials of Intervention Effectiveness-Alzheimer

2564. S96 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/s96.pdf
      October 01, 2007 - ORIGINAL ARTICLE Evaluation and Overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES) Michael A. Jhung, MD, MPH,* Daniel S. Budnitz, MD, MPH,* Aaron B. Mendelsohn, PhD,*† Kelly N. Weidenbach, MPH,* Theresa D. Nelson, MS,‡ and Daniel A. Polloc…

2565. Healthcare Industry Waste and Lifecycle Assessment (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/lifecycle-assessment-technical-brief-protocol.pdf
      August 23, 2023 - Research needs will be organized by domain (e.g., type of intervention, context) and will be sufficiently

2566. Healthcare Industry Waste and Lifecycle Assessment (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/lifecycle-assessment-protocol.pdf
      August 23, 2023 - Research needs will be organized by domain (e.g., type of intervention, context) and will be sufficiently

2567. Treating Disruptive Behavior Disorders in Children and Teens | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/disruptive-behavior-disorder/consumer
      August 31, 2016 - Treating Disruptive Behavior Disorders in Children and Teens Consumer Summary Archived August 31, 2016 Download Main Document PDF 3.6 MB Archived: This report is greater than 3 years old. Findings may be used for research purposes, but should not be considered current.   Is This Information Right…

2568. Treating Disruptive Behavior Disorders in Children and Teens (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/disruptive-behavior-disorder_consumer.pdf
      August 01, 2016 - Treating Disruptive Behavior Disorders in Children and Teens Treating Disruptive Behavior Disorders in Children and Teens A Review of the Research for Parents and Caregivers e Is This Information Right for Me? This information is for you if: � A health care professional* said your child or teen has a disrupti…

2569. Santa_ECCS2012 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/santa_eccs2012.pdf
      February 01, 2013 - Santa_ECCS2012 Slide 1: Communicating  Information About Overuse to Consumers John Santa, M.D., M.P.H. Director, Health  Ratings  Center Consumer Reports, Yonkers, New York Slide 2: Consumer Reports  in Context • Consumers choose/pu…

2570. Evidence Summary: Comparative Effectiveness Review No. 245_Breast Reconstruction After Mastectomy: A Systematic Review and Meta-Analysis (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/cer-245-breast-reconstruction-after-mastectomy-evidence-summary-updated-1.pdf
      October 01, 2021 - Evidence Summary: Comparative Effectiveness Review No. 245_Breast Reconstruction After Mastectomy: A Systematic Review and Meta-Analysis Comparative Effectiveness Review Number 245 Breast Reconstruction After Mastectomy: A Systematic Review and Meta-Analysis Evidence Summary Main Points • Im…

2571. Layout 1 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia_executive.pdf
      May 01, 2006 - Layout 1 Background Anemia (deficiency of red blood cells) occurs in 13-78 percent of patients undergoing treatment for solid tumors and 30-40 percent of patients treated for lymphoma. Tumor type, treatment regimen, and history of prior cancer therapy influence the risk and severity of anemia. For example, among pa…

2572. Type-2-Diabetes-Medications-Update Surveillance (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_surveillance.pdf
      December 31, 2013 - Evidence Table Author, Year Intervention Comparator(s) Study Design N, Population Duration Primary … mg or maximum tolerated dose Metformin (>= 1500 mg or maximum tolerated dose and Change from Intervention … At week 52, intervention resulted in greater Bosi, alogliptin (25 pioglitazone (15 with an HbA1c >= … Two severe events of hypoglycemia in intervention arm. 33

2573. Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia: Evidence Summary (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/Evidence%20Summary_1.pdf
      April 01, 2020 - However, due to small sample sizes, few trials for each intervention, and study limitations, evidence … strategies, and drug trials should specify whether participants receive a concomitant psychosocial intervention

2574. Disposition of Comments Report for Comparative Effectiveness Review #68 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/nppv-respiratory-failure_disposition-comments.pdf
      July 01, 2012 - of acute respiratory failure differs by etiology, the studies are conceptually similar in design, intervention … of acute respiratory failure differs by etiology, the studies are conceptually similar in design, intervention

2575. Juvenile-Arthritis-Dmards Surveillance (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
      March 14, 2013 - The rate and type of adverse events were generally similar between intervention and placebo groups, … The rate and type of adverse events were generally similar between intervention and placebo groups

2576. Juvenile-Arthritis-Dmards Surveillance (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
      March 14, 2013 - The rate and type of adverse events were generally similar between intervention and placebo groups, … The rate and type of adverse events were generally similar between intervention and placebo groups

2577. Research White Paper Biorepositories Addendum Registries For Evaluating Patient Outcomes Third Edition (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/biorepositories-registries-guide-3rd-ed-addendum-white-paper.pdf
      February 01, 2018 - 46.102(f), as a living individual about whom an investigator conducting research obtains data through intervention … were not collected specifically for the currently proposed research project through an interaction or intervention

2578. Research White Paper Biorepositories Addendum Registries For Evaluating Patient Outcomes Third Edition (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/biorepositories-registries-guide-3rd-ed-addendum-white-paper.pdf
      February 01, 2018 - 46.102(f), as a living individual about whom an investigator conducting research obtains data through intervention … were not collected specifically for the currently proposed research project through an interaction or intervention

2579. Disposition of Comments Report for Enzyme-Replacement Therapies for Lysosomal Storage Disease (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/lysosomal-storage-diseases-therapies_disposition-comments.pdf
      January 01, 2014 - final technical brief #10: A Technical Brief provides an overview of key issues related to a clinical intervention … or health care service—for example, current indications for the intervention, relevant patient population … subgroups of interest, outcomes measured, and contextual factors that may affect decisions regarding the intervention … information regarding Ceredase does not offer “contextual factors that may affect decisions regarding intervention

2580. Outcome Measures Framework: Literature Review Findings and Implications (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/registry-of-patient-registries_research_1.pdf
      April 15, 2019 - evaluating antithrombotic drugs in patients with acute coronary syndromes and/or percutaneous coronary intervention